Theophylline, Versus Sumatriptan and Gabapentin in The Treatment of Post-Dural Puncture Headache
Recruiting
N/A
Interventional Study
Theophylline
Sumatriptan
Gabapentin
Post-Dural Puncture Headache
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 21 – 50
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 75 (estimated)
- Sponsor
- Tanta University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The aim of this study is to compare the safety and efficacy of theophylline, sumatriptan, and gabapentin in the treatment of post-dural puncture headache.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age from 21 to 50 years.
* Both sexes.
* American Society of Anesthesiologists (ASA) physical status ≤ II.
* Patient's selection for this study will be based on clinical diagnosis suggesting post-dural puncture headache (PDPH) based on the International Headache Society criter…
Contacts